Written by MarketBeatUpdated August 25, 2025 ShareLink copied to clipboard. Key Points The article highlights **seven pharmaceutical stocks** to watch, including **Eli Lilly**, **Aptorum Group**, and **Novo Nordisk**, which had the highest trading volume recently. Eli Lilly is noted for its **extensive portfolio of diabetes and obesity medications**, such as Basaglar and Mounjaro, indicating potential growth in healthcare innovation. Aptorum Group focuses on developing treatments for **infectious diseases and cancer**, with several pipeline products targeting serious health conditions, marking it as a company to keep an eye on. Five stocks we like better than Eli Lilly and Company. Like this article? Share it with a colleague. Link copied to clipboard. Featured Articles and OffersGoldman Sachs Group Inc. Acquires 1,990,822 Shares of BigBear.ai Holdings, Inc. $BBAIBy MarketBeat | September 15, 2025Trump’s national nightmare is hereFrom Porter & Company (Ad)Intel's Silent Comeback: 3 Pillars the Market Is OverlookingBy Jeffrey Neal Johnson | September 12, 2025Baird Financial Group Inc. Invests $286,000 in BigBear.ai Holdings, Inc. $BBAIBy MarketBeat | September 15, 20252 Reasons to Scoop Up Rubrik Stock and Hold on for LifeBy Thomas Hughes | September 11, 2025Alex’s “Next Magnificent Seven” stocksFrom The Oxford Club (Ad)Oracle Has Spoken: AI Changes EverythingBy Thomas Hughes | September 10, 2025Despite Pullback, Rocket Lab Still Looks Primed for a BreakoutBy Ryan Hasson | September 10, 2025 Recent Videos Stock ListsAll Stock Lists5G Biotech Blue Chip FAANG Gold Large Cap Marijuana Micro Cap Oil REITs Russell 2000 Small Cap Warren Buffett Investing ToolsCalendars and ToolsAnalyst RatingsCryptocurrency ScreenerCongressional TradingDividend IncreasesDividend CalculatorDividend CalendarEarnings AnnouncementsInsider TradesOptions Profit CalculatorPenny StocksPortfolio MonitoringShort InterestStock ComparisonsStock Market HolidaysStock Screener Search Headlines Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Written by MarketBeatUpdated August 25, 2025 ShareLink copied to clipboard. Key Points The article highlights **seven pharmaceutical stocks** to watch, including **Eli Lilly**, **Aptorum Group**, and **Novo Nordisk**, which had the highest trading volume recently. Eli Lilly is noted for its **extensive portfolio of diabetes and obesity medications**, such as Basaglar and Mounjaro, indicating potential growth in healthcare innovation. Aptorum Group focuses on developing treatments for **infectious diseases and cancer**, with several pipeline products targeting serious health conditions, marking it as a company to keep an eye on. Five stocks we like better than Eli Lilly and Company. Like this article? Share it with a colleague. Link copied to clipboard.
